Related Experiment Video

Updated: May 11, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Identification of somatic genomic alterations in circulating tumors cells: another step forward in non-small-cell

Daniel B Costa

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |May 15, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
    07:59

    Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

    Published on: September 8, 2023

    Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization
    10:12

    Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization

    Published on: May 15, 2018

    Related Experiment Videos

    Last Updated: May 11, 2026

    Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
    05:17

    Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

    Published on: October 10, 2025

    Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
    07:59

    Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

    Published on: September 8, 2023

    Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization
    10:12

    Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization

    Published on: May 15, 2018

    Related Concept Videos

    Cancers Originate from Somatic Mutations in a Single Cell02:21

    Cancers Originate from Somatic Mutations in a Single Cell

    Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

    Articles linked to this work by shared authors, journal, and citation graph.

    Lung cancer with EGFR PACC mutations: a practical review of available treatment options and novel therapies on the horizon.

    Translational lung cancer research·2026

    A Comprehensive Mutational and Histopathological Analysis of STK11-Mutant Non-Small Cell Lung Carcinomas.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2025

    Efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry).

    Lung cancer (Amsterdam, Netherlands)·2025

    Patterns of HER2 expression and genomic correlates in lung cancer, with a focus on preanalytical variables impacting immunohistochemical staining results.

    Journal of clinical pathology·2025

    Comparative genomic and immunopathologic analysis of lung adenocarcinomas with and without cytology-proven malignant pleural effusions.

    Cancer cytopathology·2024

    Integrative single-cell RNA-seq and spatial transcriptomics analyses reveal diverse apoptosis-related gene expression profiles in EGFR-mutated lung cancer.

    Cell death & disease·2024

    Development and Validation of a Blood Test Informed Risk Prediction Model for Lung Cancer-The Copenhagen Lung Cancer Risk Model (CPH-Lung).

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Randomized Trial of Hypofractionated Postmastectomy Radiation Therapy in Women With Breast Reconstruction (RT CHARM, Alliance A221505).

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Phase I/II Study of Bavdegalutamide, a Proteolysis-Targeting Chimera Androgen Receptor Degrader, in Metastatic Castration-Resistant Prostate Cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    RINGSIDE Phase II Study of Varegacestat for Treatment of Desmoid Tumors: A Randomized Dose-Finding Clinical Trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Prognostic Impact of Telomere Maintenance Mechanisms in Neuroblastoma.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    NRG-BR002: A Randomized Phase II/III Trial of Metastasis-Directed Ablation With First-Line Systemic Therapy for Oligometastatic Breast Cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us